Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis To UK: Speed Drug Approvals, Or Else
Pharmalot
Monday, November 26, 2012 - 10:58am
tags:
UK, drug approvals, Novartis
Anika Therapeutics: Growth Stock At Value Prices With Near-Term FDA Catalyst
Seeking Alpha
Monday, November 26, 2012 - 10:57am
tags:
FDA, Anika
2 Important Decisions to Watch For This Week in the Biotech Sector
Motley Fool
Monday, November 26, 2012 - 10:56am
tags:
Theravance, Vibativ, cabozantinib, Exelis, medullary thyroid cancer, pneumonia
Exelixis's Cabozantinib Should Receive FDA Approval, But Faces Long-Term Challenges
Seeking Alpha
Monday, November 26, 2012 - 10:55am
tags:
cabozantinib, FDA, Exelixis, medullary thyroid cancer
Sucampo and Abbott Announce Launch of AMITIZA in Japan
Yahoo
Monday, November 26, 2012 - 10:54am
tags:
Abbott Labs, Sucampo, constipation, Japan, Amitiza
After 2 Drug Approvals, Can Supernus Deliver In 2013?
Seeking Alpha
Monday, November 26, 2012 - 10:26am
tags:
Supernus Pharmaceuticals, SPN-810, epilepsy, Oxtellar XR, ADHD
GSK initiates open offer to increase stake in Consumer Healthcare unit in India
Yahoo/Fly on the Wall
Monday, November 26, 2012 - 10:24am
tags:
India, GSK
The Easy Way to Make Millions on Biotechs
Motley Fool
Sunday, November 25, 2012 - 11:25am
tags:
insider trading, legal
China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2012 Financial Results
Yahoo/GlobeNewsWire
Sunday, November 25, 2012 - 11:17am
tags:
China Nuokang Bio-Pharmaceutical
Dendreon On The Ropes
Seeking Alpha
Sunday, November 25, 2012 - 11:16am
tags:
Dendreon
This Week in Biotech
Motley Fool
Sunday, November 25, 2012 - 11:15am
tags:
Arena, Vivus, Regeneron, Sanofi, MAP Pharmaceuticals, Allergan
Increased Insurance Coverage: A Big Step For Anti-Obesity Drug Manufacturers
Seeking Alpha
Sunday, November 25, 2012 - 11:13am
tags:
obesity, weight loss
A Must-See Look at Amarin's Best- and Worst-Case Scenarios
Motley Fool
Sunday, November 25, 2012 - 11:12am
tags:
Amarin
Buy, Sell, or Hold: Questcor Pharmaceuticals
Motley Fool
Sunday, November 25, 2012 - 11:11am
tags:
Questcor Pharmaceuticals
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, November 24, 2012 - 12:49pm
tags:
Pacira, Novartis
NeuroVive and Sihuan Pharmaceutical to Develop and Commercialise CicloMulsion and NeuroSTAT for Cardio- and Neuroprotection in China
PharmaLive
Saturday, November 24, 2012 - 12:26pm
tags:
CicloMulsion, NeuroSTAT, NeuroVive, Sihuan Pharmaceutical
6 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, November 24, 2012 - 12:24pm
tags:
AstraZeneca, Depomed, Avanir, GSK, Pain Therapeutics, Ampio Pharmaceuticals
Pharmaceutical company Bayer acquires nutritional supplement company Schiff
examiner.com
Saturday, November 24, 2012 - 12:21pm
tags:
Bayer, Schiff, M&A
A Note to The Pharmaceutical Industry Upon The Re-Election Of Barack Obama
Forbes
Saturday, November 24, 2012 - 12:20pm
tags:
Is Pfizer’s Stock a Buy with Lyrica?
Wall Street Cheat Street
Saturday, November 24, 2012 - 12:12pm
tags:
Pfizer, Lyrica, pain management

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.